Federated Investors Inc. PA trimmed its holdings in shares of Mednax, Inc (NYSE:MD) by 7.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,806 shares of the company’s stock after selling 3,566 shares during the quarter. Federated Investors Inc. PA owned 0.05% of Mednax worth $2,826,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in MD. Pacer Advisors Inc. raised its holdings in shares of Mednax by 3.2% in the first quarter. Pacer Advisors Inc. now owns 1,795 shares of the company’s stock valued at $125,000 after acquiring an additional 55 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in Mednax by 870.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,000 shares of the company’s stock valued at $139,000 after purchasing an additional 1,794 shares during the last quarter. Morgan Dempsey Capital Management LLC grew its stake in Mednax by 3.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 2,270 shares of the company’s stock valued at $157,000 after purchasing an additional 78 shares during the last quarter. Mn Services Vermogensbeheer B.V. grew its stake in Mednax by 4.4% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 2,428 shares of the company’s stock valued at $158,000 after purchasing an additional 102 shares during the last quarter. Finally, Daiwa Securities Group Inc. grew its stake in Mednax by 8.7% in the first quarter. Daiwa Securities Group Inc. now owns 2,500 shares of the company’s stock valued at $173,000 after purchasing an additional 200 shares during the last quarter.
Shares of Mednax, Inc (NYSE MD) opened at 43.24 on Wednesday. Mednax, Inc has a 12 month low of $41.20 and a 12 month high of $72.13. The stock has a market capitalization of $3.99 billion, a PE ratio of 13.77 and a beta of 0.40. The company’s 50 day moving average price is $45.12 and its 200 day moving average price is $57.62.
Mednax (NYSE:MD) last issued its quarterly earnings data on Friday, July 28th. The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.81 by $0.04. The business had revenue of $843.00 million during the quarter, compared to analyst estimates of $849.49 million. Mednax had a return on equity of 11.89% and a net margin of 8.78%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the company posted $1.03 EPS. Equities analysts anticipate that Mednax, Inc will post $3.31 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Federated Investors Inc. PA Sells 3,566 Shares of Mednax, Inc (NYSE:MD)” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://ledgergazette.com/2017/09/13/mednax-inc-md-stake-decreased-by-federated-investors-inc-pa.html.
Several equities analysts have issued reports on the company. Stephens upgraded Mednax from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $55.00 to $68.00 in a research note on Thursday, June 22nd. Stifel Nicolaus dropped their price target on Mednax from $65.00 to $58.00 and set a “hold” rating on the stock in a research note on Thursday, May 25th. Mizuho dropped their price target on Mednax from $64.00 to $58.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 30th. BidaskClub raised Mednax from a “strong sell” rating to a “sell” rating in a report on Tuesday, June 13th. Finally, Jefferies Group LLC set a $46.00 target price on Mednax and gave the stock a “hold” rating in a report on Sunday, July 30th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $59.88.
MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.
Receive News & Ratings for Mednax Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mednax Inc and related companies with MarketBeat.com's FREE daily email newsletter.